Why is Maitreya Medica. falling/rising?

As of 13-Nov, Maitreya Medicare Ltd is experiencing a price increase, currently at 288.65, reflecting a rise of 17.2 or 6.34%. The stock has shown strong performance today, outperforming its sector by 5.63%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Notably, there has been a significant increase in investor participation, with delivery volume rising by 301.96% compared to the 5-day average. Despite a year-to-date decline of 14.13% and a 15.89% drop over the past year, the company maintains a low Debt to EBITDA ratio of 0.30 times, indicating a strong ability to service debt, which may contribute positively to investor sentiment.
In the broader market context, Maitreya Medicare Ltd's short-term return of 25.01% over the past week significantly outpaces the Sensex's return of 1.45% during the same period. This stark contrast highlights the stock's recent strength relative to the benchmark. However, it is important to note that while the stock has shown positive short-term movements, its long-term performance remains challenged, with profits having fallen by 40% over the past year. This combination of short-term gains against a backdrop of declining profitability may create a mixed outlook for investors.